Riskpilot← Back to searchSign inGet full accessSTORBYEN LEGESENTER AS
ASActiveOrg 981622081Roald Amundsens Gate 36, 1723 SarpsborgGeneral medical practice activities · NACE 8621Est. 20004 employees
Revenue 2025
NOK 2,6M
-2% vs 2024
EBITDA margin
4.4%
-56% vs 2024
Equity ratio
71.0%
Financial strength
Net profit 2025
NOK 110K
-58% vs 2024
| Revenue | NOK 2,6M | -2% |
| EBITDA | NOK 115K | -56% |
| Net profit | NOK 110K | -58% |
| Total assets | NOK 858K | +16% |
| Equity | NOK 609K | +22% |
| Employees | 4 | — |
Legal name
STORBYEN LEGESENTER AS
Org number
981622081
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
18. april 2000
Share capital
NOK 100 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Å drive legevirksomhet, kjøp og salg samt delta i annen virksomhet ved tegning av aksjer eller på annen måte samt annet som naturlig hører herunder.
Address
Roald Amundsens Gate 36, 1723 Sarpsborg
Phone
+4769126922
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 099 | 1 923 | 2 537 | 2 667 | 2 610 |
| Staff expenses | −1 136 | −1 256 | −1 294 | −1 316 | −1 354 |
| EBITDA | 74 | −307 | 41 | 260 | 115 |
| Depreciation & amort. | −68 | −54 | −54 | −0 | −0 |
| EBIT | 6 | −361 | −14 | 259 | 115 |
| Net financials | −0 | 0 | 1 | 1 | 0 |
| Profit before tax | 6 | −361 | −13 | 261 | 115 |
| Tax | 5 | −0 | −0 | −0 | 5 |
| Net profit | 1 | −361 | −13 | 261 | 110 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 839 | 463 | 462 | 743 | 858 |
| Equity | 619 | 252 | 239 | 499 | 609 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 220 | 211 | 224 | 243 | 249 |
| Total debt | 220 | 211 | 224 | 243 | 249 |
EBITDA margin
4.4%
This company
15.8%
Market median
-72% vs market
20212025
Equity ratio
71.0%
This company
38.2%
Market median
+86% vs market
20212025
Return on equity
18.1%
This company
18.4%
Market median
+2% vs market
20212025
Net profit margin
4.2%
This company
8.1%
Market median
-48% vs market
20212025
Asset turnover
3.04×
This company
1.12×
Market median
+171% vs market
20212025
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
UA Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (1) | ||
BA Chief Executive Officer | Chief Executive Officer | 2000 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 33.33% | 33.33% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of STORBYEN LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Benny Adelved | Chief Executive Officer | 0 companies |
| Usama Abid | Chief Executive Officer | 0 companies |
| Ceren Tamguler Barreto Rios | Board of Directors | 0 companies |
| Alexandra Utgaard-Haugbro | Chairman | 0 companies |